Longevity Startups in India: Can Science Make Healthy Ageing Accessible?

For decades, healthcare has largely focused on diagnosing and treating diseases once symptoms appear.

Longevity Startups are exploring a different approach: understanding how the body changes with age and identifying opportunities to maintain health before serious problems develop.

Why Are Longevity Startups in India Gaining Attention? 

Longevity startups in India are helping shift attention from treating illness to identifying health risks earlier and supporting healthy ageing. But whether these services improve long-term health remains an important question.

According to the United Nations Population Fund (UNFPA), India's population aged 60 and above is projected to reach approximately 347 million by 2050.

This demographic shift could increase demand for preventive healthcare, better chronic disease management, and services that help older adults remain independent.

It also raises a larger question: can advances in longevity science reach ordinary Indians, rather than remaining limited to expensive healthcare programmes?

What Does Longevity Science Actually Study?

Longevity science examines the biological processes associated with ageing and how they influence health, physical function and disease risk.

A landmark 2023 review published in Cell described 12 interconnected hallmarks of ageing. These include:

• Genomic instability: Damage and changes affecting genetic material.
• Mitochondrial dysfunction: Changes in how cells produce and manage energy.
• Cellular senescence: Cells entering a state in which they stop dividing but can remain biologically active.
• Chronic inflammation: Persistent inflammatory processes associated with ageing.
• Gut microbiome changes: Alterations in the microorganisms living in the digestive tract.

These mechanisms help researchers investigate why people experience ageing differently.

Which Longevity Startups in India Are Shaping the Industry?

India's emerging longevity industry is attracting entrepreneurs and investors who believe healthcare needs to begin before disease develops.

Biopeak: Specialist-Led Preventive Healthcare

• Bengaluru-based Biopeak focuses on preventive healthcare programmes that combine advanced diagnostics, clinical expertise, and ongoing health monitoring.
• In January 2026, the company raised $2.7 million in a funding round led by NKSquared, Nikhil Kamath's investment vehicle.
• The investment was intended to support the expansion of its clinical services, diagnostics, and research capabilities.
  

Gabit: Making Health Tracking Part of Everyday Life

• Founded by Gaurav Gupta and Arpana Shahi, Gabit approaches preventive care through wearable technology and connected health data.
• Its ecosystem combines a smart ring, lifestyle tracking, blood tests, and AI-assisted health insights.
• According to a July 2026 report, the company is developing a platform that integrates information related to nutrition, physical activity, sleep, and stress.
  

Still, a wearable score or personalised recommendation is not automatically a clinically validated assessment of biological ageing.

Decode Age: Biological Age and Gut Health Insights

• We operate within India's longevity and wellness sector, offering biological age assessments, gut microbiome testing, educational resources, and health supplements.
• Our approach reflects growing interest in using biological information to understand individual health patterns.
• For example, biological age testing uses selected biomarkers to estimate aspects of ageing.
• Similarly, gut microbiome testing examines microorganisms and their genetic information.

For a broader explanation, explore the difference between healthy ageing and anti-ageing.

Can We Really Slow Biological Ageing? 

As the industry expands, one distinction becomes increasingly important: measuring biological changes is not equivalent to proving that human ageing has slowed. 

In a January 2026 interview, our Co-founder Rakesh Somani reflected on the transition from personal biohacking to building a science-led organisation. 

"I had to learn to separate what worked for me personally from what could be responsibly recommended to thousands of people."

That distinction matters across the longevity industry. 

Biological age estimates, DNA methylation patterns, and other biomarkers can provide useful research information, but they require validation before being used to guide clinical decisions.

A 2024 review in Nature Medicine highlighted the scientific challenges involved in establishing reliable ageing biomarkers. 

For India, meaningful progress will require more than promising biological age scores. Changes in laboratory markers may be useful for research signals, but what human studies demonstrate is that meaningful health outcomes matter more than anti-ageing claims.

It will require validated tools, reproducible findings, and evidence that interventions improve outcomes people experience.

India's Longevity Revolution Needs More Than Innovation 

India's longevity sector is advancing at the intersection of biotechnology, consumer health and preventive medicine. Yet scientific progress and commercial growth are not necessarily moving at the same pace.

The BHARAT Study could help establish stronger population-specific evidence, while startups continue experimenting with how to translate complex health information into everyday decisions. The next phase of the industry should not be measured solely by investments raised, biomarkers tracked, or tests sold.

The more meaningful benchmarks will be scientific validation, affordability, sustained behaviour change, and measurable improvements in health.

FAQs

1. What are longevity startups in India?

Longevity startups in India develop services or technologies related to healthy ageing, preventive healthcare, diagnostics, health tracking, and personal wellbeing. Examples include Biopeak, Gabit, and Decode Age.

2. What is the BHARAT Study?

The BHARAT Study is an IISc-led research initiative examining biological, clinical, and lifestyle markers of ageing in Indian populations. Its 2026 paper describes the research design, not an established anti-ageing treatment.

3. Are biological age tests accurate?

Their accuracy and clinical usefulness depend on the specific test, population, and intended application. Some biomarkers show promise in research, but many still require further validation before routine clinical use.

4. Can longevity supplements reverse ageing?

No, there is insufficient evidence that commercially available longevity supplements can reliably reverse human ageing or extend lifespan. Benefits should be evaluated using well-designed human trials and meaningful clinical outcomes.

5. How can I improve my healthspan without expensive tests?

Regular physical activity, balanced nutrition, adequate sleep, alcohol avoidance, and appropriate preventive healthcare are sensible starting points for maintaining health and independence.